Cutaneously applied 4-hydroxytamoxifen is not carcinogenic in female rats.

@article{Sauvez1999CutaneouslyA4,
  title={Cutaneously applied 4-hydroxytamoxifen is not carcinogenic in female rats.},
  author={F Sauvez and Denis Drouin and Mohamed Hbib Ben Attia and H. Bertheux and Roy P. Forster},
  journal={Carcinogenesis},
  year={1999},
  volume={20 5},
  pages={843-50}
}
Tamoxifen is widely used to treat oestrogen-dependent carcinoma of the breast. Previous long-term studies have shown that oral administration of tamoxifen induces hepatoproliferative lesions and hepatocellular tumours in rats. 4-hydroxytamoxifen is an active metabolite of tamoxifen undergoing clinical evaluation for the treatment of various non-malignant breast diseases by topical application. In the present study, 4-hydroxytamoxifen was administered daily by cutaneous application for 101 weeks… CONTINUE READING
8 Citations
17 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Similar Papers

Loading similar papers…